Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Molecular Cancer Therapeutics|November 24, 2006
Ornithine decarboxylase activity in tumor cell lines correlates with sensitivity to cell death induced by histone deacetylase inhibitorsLaura R Saunders, Eric Verdin
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 30, 2003
The dsRNA binding protein family: critical roles, diverse cellular functionsLaura R Saunders, Glen N Barber
Aging|July 17, 2010
miRNAs regulate SIRT1 expression during mouse embryonic stem cell differentiation and in adult mouse tissuesLaura R Saunders, Amar Deep Sharma, Jaime Tawney, et al.
Molecular Cancer Research : MCR|July 23, 2008
Destabilization of ERBB2 transcripts by targeting 3' untranslated region messenger RNA associated HuR and histone deacetylase-6Gary K Scott, Corina Marx, Crystal E Berger, et al.
Translational Oncology|October 19, 2020
Rova-T enhances the anti-tumor activity of anti-PD1 in a murine model of small cell lung cancer with endogenous Dll3 expressionPhilip Vitorino, Chen-Hua Chuang, Alexandre Iannello, et al.
The Oncologist|May 7, 2020
Delta-Like Protein 3 Expression and Targeting in Merkel Cell CarcinomaHao Xie, Frederic J Kaye, Kumiko Isse, et al.
Bioconjugate Chemistry|April 9, 2021
Synthesis and Comparative <i>In Vivo</i> Evaluation of Site-Specifically Labeled Radioimmunoconjugates for DLL3-Targeted ImmunoPETSai Kiran Sharma, Pierre Adumeau, Outi Keinänen, et al.
Science (New York, N.Y.)|December 11, 2012
Suppression of oxidative stress by β-hydroxybutyrate, an endogenous histone deacetylase inhibitorTadahiro Shimazu, Matthew D Hirschey, John Newman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2017
Venetoclax Is Effective in Small-Cell Lung Cancers with High BCL-2 ExpressionTimothy L Lochmann, Konstantinos V Floros, Mitra Naseri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2018
Transcriptomic and Protein Analysis of Small-cell Bladder Cancer (SCBC) Identifies Prognostic Biomarkers and DLL3 as a Relevant Therapeutic TargetVadim S Koshkin, Jorge A Garcia, Jordan Reynolds, et al.
Pageof 2